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Pyrazofurin (PZF), a cytidine analog and an inhibitor of orotate monophosphate decarboxylase, has been shown to
decrease the levels of UTP and CTP in treated cells. When Sindbis virus (SV)-infected Aedes albopictus cells were treated
with PZF, the yield of virus was reduced 100- to 1000-fold. By serial passage of our standard SVSTD in Ae. albopictus cells in
the presence of increasing concentrations of PZF, a mutant, SVPZF, was derived, which was not inhibited by PZF. SVPZF is also
resistant to adenosine, guanosine, and phosphono-acetyl-N-aspartate, all of which have been shown to decrease levels of
UTP and CTP. Analysis of chimeric viruses containing sequences from the SVPZF and parental genomes showed that the
sequence between nt 5262 and 7999 conferred the PZF-resistant phenotype. Sequencing of this region identified four
mutations (nt 5750, 6627, 7543, and 7593), which are predicted to lead to amino acid changes: opal550L in nsP3 and M287L,
K592I, and P609T in nsP4. Characterization of viruses containing one or more of these mutations demonstrated that all three
mutations in the nsP4 coding region are required to produce full resistance to PZF. Using a molecular model of nsP4 based
on the structure of HIV reverse transcriptase, we located amino acid change M287L at the tip of the fingers domain and K592I
and P609T at the base of the thumb domain of the viral RNA polymerase. We suggest that these three amino acid changes
in nsP4 alter the geometry of the NTP binding pocket so as to increase the affinity of the enzyme for CTP and UTP. © 2000
Academic PressINTRODUCTION
Sindbis virus is the prototype virus of the genus alpha-
virus, family Togaviridae. Its genome is a single-stranded
RNA, of messenger polarity, about 11700 nucleotides in
length. The 59 end of the RNA has a type 0 cap, and the
39 end is polyadenylated. In addition to the genomic
RNA, another viral mRNA, the subgenomic or 26S RNA, is
found in infected cells. The sequence of the 26S RNA,
which encodes the viral structural proteins, is identical to
that of the 39 third of the genomic RNA. Like the genomic
RNA, the subgenomic RNA is capped and polyadenyl-
ated (see Strauss and Strauss, 1994, for a review).
The genomic RNA encodes the four nonstructural (ns)
proteins: nsP1, nsP2, nsP3, and nsP4. These proteins are
generated by the processing of two polyproteins: p123,
which gives rise to nsP1, nsP2, and nsP3, and p1234,
which gives rise to all four of the ns proteins. p123 is
made when the ribosome recognizes an opal codon near
the 39 end of the nsP3 coding sequence. At a low fre-
quency (10–20% in vitro), the ribosome reads through the
opal codon, and p1234 is made (DeGroot et al., 1990; Li
and Rice, 1993). Thus nsP4 is made in lesser amounts1 To whom reprint requests should be addressed. Fax: (732) 235-
223. E-mail: stollar@umdnj.edu.
61than the other three ns proteins. Because there are
several stop codons at the end of the nsP4 coding
sequence, the structural proteins are not translated from
the genomic RNA.
The four ns proteins exist within infected cells as a
multiprotein complex (Barton et al., 1991), the function of
which is to replicate and transcribe the viral RNAs. Ex-
actly how these proteins interact in this complex is not
known. However, there is some information about the
functions of the individual proteins. nsP1 has both GTP
methyltransferase activity (Mi et al.,1989; Mi and Stollar,
1990) and RNA guanylyltransferase activity (Ahola and
Ka¨a¨riaianen, 1995) and is thus assumed to be responsi-
ble for the modification of the 59 terminus of the two viral
mRNAs. nsP2 has an N-terminal domain, with helicase
activity (Gomez et al., 1999), which is presumably respon-
sible for the unwinding of the fully or partially dsRNAs
during replication and translation, and a C-terminal pro-
tease domain, responsible for processing of the p123
and p1234 polyproteins (Hardy and Strauss, 1989). The
function of nsP3 is not known. However, it is the only ns
protein that is phosphorylated (Peranen et al., 1988; Li et
al., 1990). nsP4 contains a GDD sequence, the hallmark
of nearly all viral RNA-dependent RNA polymerases
(RDRPs) (Kamer and Argos, 1984). There also is good
genetic evidence that nsP4 is the RDRP (Barton et al.,
1988).
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62 LIN ET AL.Synthesis of the different forms of alphavirus RNA is
controlled both temporally and quantitatively. Minus-
strand RNA is made only early in infection, whereas
plus-strand RNA is made both early and late (Sawicki
and Sawicki, 1986). Minus-strand RNA is also made in
much lesser amounts than plus-strand RNA. Early in
infection, when processing of the ns polyproteins is in-
complete, the replication complex contains mainly p123
and nsP4, or nsP1, p23, and nsP4. As the infection
progresses, the efficiency of processing of the ns
polyproteins increases, and the replication complexes
then contain only the fully processed ns proteins, nsP1,
nsP2, nsP3, and nsP4 (Lemm et al., 1994). These findings
ndicate that the processing of the ns proteins might
overn the type of viral RNA that is made. Based on the
esults of experiments with ts mutants, Wang et al. (1994)
resented a model suggesting that p23 was an essential
omponent of the minus-strand polymerase. Subse-
uently, by making use of recombinant vaccinia virions to
upply both a positive-strand template and the Sindbis
irus ns proteins, in either their processed or unproc-
ssed forms, Lemm et al. (1998) showed that minus-
trand RNA was made only when the replication com-
lexes contained p123 or p23. When the ns proteins
ere completely processed, the replication complexes
ere no longer capable of making minus-strand RNA.
he crucial step in this transition appears to be the
leavage of p23 to nsP2 and nsP3.
To synthesize the subgenomic RNA, the replication
omplex must recognize an internal promoter on the
inus-strand RNA. The minimal sequence essential for
his promoter extends from nucleotide 219 to 15, rela-
ive to the initiation site (nt 7598) for the transcription of
he subgenomic RNA (Levis et al., 1990). How the ns
roteins are arranged in the replication complex that
akes subgenomic RNA and whether this arrangement
iffers from that in the complex that makes full-length
iral RNA are not known.
Additional information concerning the control of viral
NA synthesis and the functions of the ns proteins in this
rocess has emerged from the study of ts mutants of
indbis virus. For example, ts-11, the causal mutation of
hich is in the nsP1 coding region, can no longer syn-
hesize minus-strand RNA at the nonpermissive temper-
ture, even though the synthesis of plus-strand RNA
ontinues without interruption (Wang et al., 1991). Thus
sP1 must be necessary for the synthesis of minus-
trand RNA. ts-24, and ts1 revertants of ts-24, continue to
ynthesize minus-strand RNA at the elevated tempera-
ure well after the time it would normally cease. The
utation responsible for this phenotype is in the nsP4
oding region and changes Gln 191 to Lys (Strauss and
trauss, 1994; Suopanki, et al., 1998). ts-24 is also defec-
ive in the synthesis of 26S subgenomic RNA at theonpermissive temperature. ts-6, which maps to the
sP4 coding region, ceases all viral RNA synthesis at the
onpermissive temperature (Barton et al., 1988), support-
ng the hypothesis that nsP4 is the RDRP.
We began the work described here with the goal of
btaining mutants of Sindbis virus that encoded an al-
ered RDRP, with amino acid changes that would point to
esidues important for the binding of the ribonucleotide
riphosphate (rNTP) substrates. To do this, we used an
pproach similar to that used previously to select our
VLM21 and SVMPA mutants; we selected for virus able to
eplicate in cells with decreased levels of a substrate
ritical for viral replication (Durbin and Stollar, 1985,
cheidel et al., 1987). Thus SVLM21 is able to grow in
edes albopictus mosquito cells that have been de-
rived of methionine and should contain low levels of
-adenosylmethionine, and SVMPA is able to replicate in
Ae. albopictus cells treated with mycophenolic acid, a
compound that interferes with the synthesis of GMP.
Such cells therefore are expected to contain low levels of
GTP.
To obtain a mutant Sindbis virus that encodes an
RDRP with altered substrate binding properties, we de-
cided to select for virus that can grow in cells with low
levels of one or more of the rNTP substrates. Pyrazofurin
(PZF) is a cytosine analog that, in its monophosphate
form, inhibits orotidine monophosphate (OMP) decarbox-
ylase and thus interferes with the synthesis of pyrimidine
nucleotides, thereby lowering intracellular levels of UTP
and CTP (Cadman et al., 1978; Dix et al., 1979). After
demonstrating that PZF inhibited the replication of SVSTD
in Ae. albopictus cells, we were able to select a viral
mutant, SVPZF, that is resistant to this drug. In this report,
we describe the properties of SVPZF and identify three
mutations found in the nsP4-coding region of the SVPZF
genome.
RESULTS
Isolation and characterization of SVPZF
Figure 1 shows that in mosquito cells, the replication
of SVSTD was readily inhibited by PZF. At 2.5 mM PZF, the
yield of virus in the medium was reduced more than
1000-fold, and at 5.0 mM PZF, maximum inhibition was
observed. When CEF or BHK cells were similarly infected
with SVSTD and treated with PZF, no reduction in virus
yield was noted.
To obtain a viral mutant resistant to PZF, Sindbis virus
was serially passaged without dilution in Ae. albopictus
cells in the presence of increasing concentrations of PZF.
We began with SVSTD and carried out a total of 38 pas-
sages, each time harvesting the progeny virus 24 h after
infection. Infected cells were maintained in the presence
of 2.5 mM PZF for 8 passages, 5.0 mM for 10 passages,
10 mM for 12 passages, and 15 mM PZF for 8 passages.
At the end of the virus passage, the resulting virus was
yP
m
g
a
P
C
m
p
o
w
o
t
a
o
b
i
i
w
63SINDBIS VIRUS MUTANT ENCODES ALTERED RNA POLYMERASEplaque-purified on CEF and then grown to a stock in CEF.
The titer of this stock was 1.3 3 109 PFU/ml.
Figure 2 shows that although 2.5 mM PZF reduced the
ield of SVSTD from infected mosquito cells by approxi-
mately 1000-fold, there was no reduction in the yield of
virus from SVPZF-infected cells that were similarly treated.
On the contrary, at low concentrations of PZF, the yield of
SVPZF was actually increased; in this experiment, the yield
FIG. 1. Effect of PZF on the replication of SVSTD in Ae. albopictus cells.
Cells were infected at an m.o.i. of 5 PFU/cell as described in the text
and incubated at 34.5°C. Medium was harvested at 24 h p.i. and
assayed for infectious virus by plaque assay on CEF.
FIG. 2. Replication of SVSTD (E) and SV PZF (F) in Ae. albopictus cells
n the presence of different concentrations of PZF. Cells were infected
ith either SVSTD or SVPZF at an m.o.i. of 5 PFU/cell and maintained as
t
S
described for Fig. 1. Medium was harvested at 24 h p.i. and assayed for
infectious virus by plaque assay on CEF.increased about 10-fold over that from untreated cells.
Similar increases in the yield of infectious SVPZF virus at
ZF concentrations of 0.5 to 2.5 mM were observed in
ost experiments of this type.
In earlier work, we showed that both adenosine and
uanosine reduced the yield of SV from infected Ae.
lbopictus cells. Because both of these nucleosides, like
ZF, lower the intracellular concentrations of UTP and
TP (Stollar and Malinoski, 1981), we wanted to deter-
ine whether SVPZF might be cross-resistant to these
urine nucleosides. Table 1 shows that although aden-
sine reduced the yield of SVSTD up to 1000-fold, there
as no effect on the titer of SVPZF. Similar findings were
bserved with guanosine. Thus SVPZF is cross-resistant
o both adenosine and guanosine. SV PZF was not tem-
perature sensitive, nor was it resistant to mycophenolic
acid, an inhibitor of GMP synthesis.
Although we undertook these experiments with the
assumption that PZF inhibited viral replication by reduc-
ing the intracellular concentrations of UTP and CTP to
levels incompatible with viral RNA synthesis, we did
consider another possibility to explain the effect of PZF.
It has been shown that PZF is phosphorylated to the
monophosphate, diphosphate, and triphosphate levels in
L1210 leukemia cells (Sant, 1989). Thus it is possible that
the triphosphate form of PZF might be recognized by the
viral RDRP, interfere with the binding of the other rNTPs
at the catalytic site of the RDRP, and inhibit virus repli-
cation in this way.
Like PZF, N-phosphonoacetyl-L-aspartate (PALA) is an
inhibitor of pyrimidine biosynthesis, but it acts at an
earlier stage than does PZF, by preventing the conden-
sation of L-aspartate and carbamoyl phosphate (Collins
nd Stark, 1971). However, because PALA is not a nucle-
side analog, it is not expected to bind to the substrate
inding site of the RDRP. Thus if PALA were able to
nhibit the replication of viral RNA, it would be expected
TABLE 1
Cross-Resistance of SVPZF to Adenosine and Guanosine
Virus Adenosine (mM) Guanosine (mM) Yield (PFU/ml)
SVSTD 0 0 2.2 3 10
8
300 0 2.0 3 106
0 300 3.9 3 106
SVPZF 0 0 4.3 3 10
7
300 0 5.7 3 107
0 300 2.5 3 108
Note. Cells were infected at an m.o.i. of 5 PFU/cell. After adsorption
at 28°C for 1 h, cells were re-fed with medium containing 1% dialyzed
fetal calf serum and the indicated concentrations of either adenosine or
guanosine and were incubated at 28°C. Medium was harvested at 20
h p.i. and assayed for infectious virus by plaque assay on CEF.o do so only by lowering the levels of UTP and CTP. If
VPZF were cross-resistant to PALA, it would be highly
ra
S
a
v
y
64 LIN ET AL.likely that both compounds inhibited viral replication via
the same mechanism.
Figure 3 shows that PALA inhibits the replication of
SVSTD in mosquito cells (as was the case with PZF, PALA
had no effect on virus replication in BHK cells; data not
FIG. 3. Effect of PALA on the replication of SVSTD and SVPZF in Ae.
albopictus cells. The experimental procedure was the same as de-
scribed for Fig. 2 except that PALA was used instead of PZF.FIG. 4. Chimeric Sindbis virus genomes containing various sequences deriv
boxes represent sequences from SVPZF.shown) and demonstrates that SVPZF is cross-resistant to
PALA. We conclude, therefore, that PZF and PALA inhibit
the replication of Sindbis virus in mosquito cells in a
similar manner (i.e., by reducing the levels of UTP and
CTP).
Localization and identification of the mutations
responsible for the resistance to PZF
To determine which region of the SVPZF genome is
esponsible for the drug-resistant phenotype of SVPZF, we
constructed chimeric Sindbis viruses containing various
SVPZF cDNA sequences in an SVToto background (Fig. 4)
nd tested them for resistance to PZF.
The three chimeric viruses that contained the entire
VPZF nsP4-coding region were resistant to PZF (Table 2).
These included SVToto:PZF:41-7999, SVToto:PZF:2784-7999,
nd SVToto:PZF:5262-7999. As was the case with SVPZF,
each of these viruses produced a higher yield in the
presence of 2.5 mM PZF than in its absence. Chimeric
iruses containing the SVPZF nt sequence only from nt 41
to 2784 or from nt 5262 to 7334 (i.e., lacking all or part of
the SVPZF nsP4-coding sequence) were sensitive to PZF.
The status of SVToto:PZF:7334-7999, which contains only
the SVPZF sequence coding for the C-terminal two thirds
of NSP4, remains indeterminate. In contrast to SVPZF, the
ield of SVToto:PZF:7334-7999 did not increase in the pres-
ence of 2.5 mM PZF; however, neither did its yield drop
very significantly, as is generally seen with virus that is
completely sensitive.
Because the SVPZF sequence from nt 5262 to 7999 was
the smallest segment that could clearly transfer the PZF-
resistant phenotype, we sequenced this entire region.ed from SVPZF RNA. Open boxes represent sequences from pToto. Solid
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65SINDBIS VIRUS MUTANT ENCODES ALTERED RNA POLYMERASEFour mutations were found that are predicted to result in
amino acid changes (Table 3). The first mutation, at nt
5750, changes the opal codon near the 39 end of the
nsP3-coding region to a Cys codon. The other three
mutations occur in the nsP4 coding region at nt 6627,
7543, and 7593 and change Met 287 to Leu, Lys 592 to
Ile, and Pro 609 to Thr (Sindbis virus nsP4 has 610 amino
acids). It is noteworthy that the mutation at nt 7593
occurs at the 25 position of the minimal promoter for the
synthesis of the subgenomic 26S RNA (taking the first nt
of the transcript as the 11 position; Levis et al., 1990).
There were, in addition, two silent mutations in the nsP3
coding region: C5393U (Ala 431) and U5444A (Ser 448).
Site-directed mutagenesis
To determine which of these mutations is responsible
for the resistance to PZF, we used site-directed mutagen-
esis to introduce the mutations listed in Table 3 into
SVToto, either one at a time or in combinations. For the
ake of convenience, in this discussion and in Table 4,
he mutations at nt 5750, 6627, 7543, and 7593 are re-
erred to as mutations 1, 2, 3, and 4, respectively.
The introduction of mutations 1, 2, 3, or 4, one at a time,
id not in any case produce resistance to PZF. When the
utations were introduced two at a time, the only com-
inations that led to PZF resistance were 2/4 and 3/4, but
TABLE 2
Phenotypes of Chimeric Viruses Containing Various SVPZF
Sequences
Virus PZF (mM) Yield (PFU/ml) Phenotype
VSTD 0 2.1 3 10
9 Sensitive
2.5 1.4 3 107
SVPZF 0 1.9 3 10
8 Resistant
2.5 1.4 3 109
SVToto:PZF:41-2784 0 2.8 3 10
9 Sensitive
2.5 1.1 3 106
SVToto:PZF:2784-7999 0 4.2 3 10
7 Resistant
2.5 2.1 3 108
SVToto:PZF:41-7999 0 1.2 3 10
8 Resistant
2.5 3.9 3 108
SVToto:PZF:5262-7999 0 6.0 3 10
7 Resistant
2.5 3.1 3 108
SVToto:PZF:5262-7334 0 1.5 3 10
9 Sensitive
2.5 1.1 3 107
SVToto:PZF:7334-7999 0 9.8 3 10
7 ?
2.5 2.2 3 107
Note. Cells were infected at an m.o.i. of 5 PFU/cell with SVSTD, SVPZF,
or the chimeric viruses shown above. After adsorption at 34.5°C for 1
h, cells were re-fed with serum-free medium containing 0.2% BSA in the
presence or absence of 2.5 mM PZF and then incubated at 34.5°C.
edium was harvested at 24 h p.i. and assayed for infectious virus by
laque assay on CEF.n neither case was the resistance as great as that seen
ith SVPZF.Combinations of the SVPZF mutations three at a time
ed to resistance only if mutation 4 was present, but a
henotype similar to that of SVPZF was seen only with
mutations 2, 3, and 4. The combinations 1/2/4 and 1/3/4
gave only partial resistance. We conclude from these
results that mutation 4 is essential for resistance to PZF
and that mutation 1 is not required. Mutations 2 and 3
clearly enhanced the effect of mutation 4, and when both
mutations 2 and 3 were combined with mutation 4, the
full SVPZF phenotype was expressed.
TABLE 3
Mutations in SVPZF
Nucleotide change Amino acid change
A 5750 U Opal 550 Leua
A 6627 U Met 287 Leub
A 7543 U Lys 592 Ileb
C 7593 A Pro 609 Thrb
a In nsP3.
b In nsP4.
TABLE 4
Phenotypes of Viruses with Various SVPZF Mutations
Virus Phenotypeb
SVSTD S
SVPZF R
Virus with mutation(s)a
1 S
2 S
3 S
4 S
1, 2 S
1, 3 S
1, 4 S
2, 3 S
2, 4 r
3, 4 r
1, 2, 3 S
1, 2, 4 r
1, 3, 4 r
2, 3, 4 R
1, 2, 3, 4 R
Note. Cells were infected at an m.o.i. of 5 PFU/cell with SVSTD, SVPZF,
or the mutagenized viruses shown above. After adsorption at 34.5°C for
1 h, cells were refed with serum-free medium containing 0.2% BSA, in
the presence or absence of 2.5 mM PZF, and then incubated at 34.5°C.
Medium was harvested at 24 h p.i. and assayed for infectious virus by
plaque assay on CEF.
a Mutation 1, nt 5750; mutation 2, nt 6627; mutation 3, nt 7543;
utation 4, nt 7593.
b S denotes that PZF reduced the virus yield at least 30-fold, but
usually 100-fold. R denotes that PZF increased the virus yield several-
f
o
old or even up to 10-fold; r denotes that PZF reduced the virus yield but
nly threefold to fourfold.
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66 LIN ET AL.Molecular model of nsP4
To understand the effects of the amino acid changes in
SVPZF nsP4 on the structure and function of the SV RDRP,
it would be necessary to know the location in the protein
of the altered amino acid residues and the relationships
of these residues to conserved motifs that function in
catalysis or binding of substrate or primer. Because no
structure has been described for any alphavirus RDRP,
we undertook to generate a molecular model of the SV
nsP4 using the poliovirus RDRP (Hansen et al., 1997) and
the HIV reverse transcriptase (Huang et al., 1998) as the
reference molecules. Because the four sequence motifs,
A, B, C. and D, common to viral RDRPs (Poch et al., 1989)
are all present within the nsP4 sequence from 251 to 610,
the first 250 amino acids were not used in constructing
our model of nsP4.
In the model of nsP4 obtained using the polio virus 3D
RDRP as the reference molecule, residues 592 and 609
were both located near the base of the thumb domain
(not shown). However, in determining the structure of the
poliovirus RDRP, there were several disordered regions
(Hansen et al., 1997), which could not be included in the
FIG. 5. A molecular model of SV nsP4. The amino acid sequence for S
aligned to the HIV-RT (access code p03366) using the consensus moti
f SV nsP4 were calculated by the command “homology modeling” in
y Poch et al. (1989) are shown in green, blue, magenta, and yellow, res
and D466 are in the GDD sequence of motif C, and D370 is the consestructure. As a result, the corresponding regions of the
SV nsP4 were also missing in our molecular model.We therefore turned to the HIV reverse transcriptase
as the reference molecule. This molecule has been stud-
ied extensively, there are no gaps in its structure, and its
structure has been determined with bound template-
primer as well as bound substrate (Huang et al., 1998).
As shown in Fig. 5, in the molecular model of nsP4 that
we obtained using the HIV RT as the reference molecule,
residues 592 and 609 were again found at the base of
the thumb domain; however, with this model, we were
now able to locate residue 287 to a loop at the tip of the
fingers domain.
DISCUSSION
The first collections of Sindbis virus mutants were
generated by means of random chemical mutagenesis
(Burge and Pfefferkorn, 1966; Strauss et al., 1976; Strauss
and Strauss, 1980). These mutants, which had been
selected on the basis of their ts phenotype, were sepa-
rated into seven complementation groups. Mutants in
complementation groups C, D, and E were RNA1 (i.e.,
they were able to make viral RNA at the nonpermissive
temperature). The mutations responsible for the pheno-
, which was translated from the nucleotide sequence gb_vi:sincg, was
ribed by Poch et al. (1989) and the Look 3.0 program. The coordinates
.0 and then displayed using Ribbons. Motifs A, B, C, and D described
ly. The amino acid changes in SVPZF nsP4 are labeled in orange. D465
sp in motif A.V nsP4
fs desc
Look 3types of these mutants mapped to the genes for the
structural proteins. The mutants in complementation
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67SINDBIS VIRUS MUTANT ENCODES ALTERED RNA POLYMERASEgroups A, B, F, and G were RNA2 (i.e., they were not able
to make viral RNA at the nonpermissive temperature).
The mutations responsible for the phenotypes of these
mutants were mapped to the regions encoding the ns
proteins: nsP1, nsP2, nsP3, and nsP4 (Hahn et al.,
1989a,b). Mutants with mutations in the genes coding for
the ns proteins have proved to be useful in understand-
ing the regulation of viral RNA synthesis and in associ-
ating specific functions with ns proteins. For example,
experiments with ts-6 (complementation group F) were
important in identifying nsP4 as the viral RDRP (Barton et
al., 1988).
We have used a different approach to obtain mutants
with alterations in ns proteins. There are only five small
molecules that serve as substrates for virus-coded ns
proteins: ATP, GTP, CTP, and UTP, which are substrates
for the viral RDRP (GTP is also a substrate for the viral
guanylyltransferase), and S-adenosylmethionine (AdoMet),
which is a substrate for the viral RNA methyltransferase. We
reasoned that if the intracellular concentration of any of
these fell below a critical value, viral replication would be
inhibited, and that if we could isolate viral mutants capable
of growth under these conditions, mapping of the sites of
such mutations should allow identification of the ns pro-
teins that interacted with these small molecules. Such in-
formation should then provide clues as to the function of the
ns proteins. We used this approach to determine that mu-
tations in the nsP1 gene allow growth under conditions of
low GTP or AdoMet. This was instrumental in identification
of nsP1 as the protein responsible for capping viral mRNAs
(Durbin and Stollar, 1985; Mi et al., 1989; Scheidel and
Stollar, 1991). In the work reported here, our goal was to
obtain a mutant that would encode an RDRP (i.e., nsP4) with
alterations in its rNTP substrate binding properties. Accord-
ingly, we sought a mutant that could replicate in cells
treated with PZF and that therefore should have low levels
of UTP and CTP. We obtained the desired mutant (i.e.,
SVPZF), and the mutations responsible for the mutant phe-
notype did, as expected, map to the nsP4 coding region. We
anticipate that SVPZF will be a useful addition to the several
s mutants previously shown to map to the nsP4 coding
egion and that it will be useful in understanding the struc-
ure-function relationships of nsP4.
When we added either adenosine or guanosine to
nfected Ae. albopictus cells, SVPZF, in contrast to SVSTD,
as resistant to both of these purine nucleosides. In
iew of our earlier demonstration that the addition of
denosine or guanosine to Ae. albopictus cells lowers
he level of UTP and CTP in these cells (Stollar and
alinoski, 1981) and our demonstration here that SVPZF
can replicate in cells with low levels of UTP and CTP, this
result was not surprising. Similarly, our finding that SVPZF
actually produces somewhat higher yields from cells
treated with low levels of PZF than from untreated cells
is consistent with the idea that SVPZF is adapted to cells
ontaining lowered levels of UTP and CTP.
a
BThe cross-resistance of SVPZF to PALA reinforces the
indings just described with adenosine and guanosine
nd lends further support to the idea that when mosquito
ells are treated with PZF, it is the decrease in the
oncentration of the pyrimidine nucleotide triphosphates
hat is responsible for inhibition of viral replication. This
eing the case, the simplest explanation for the resis-
ance of SVPZF to PZF is that by virtue of an increased
ffinity for UTP and/or CTP, the SVPZF RDRP is able to
function in cells with decreased levels of these com-
pounds.
Characterization of chimeric viruses containing vari-
ous SVPZF sequences in an SVToto background indicated
that the mutations responsible for the resistance to PZF
were contained in the SVPZF genome sequence extending
rom nt 5262 to 7999. This sequence includes part of the
sP3 coding region, all of the nsP4 coding region, and
he sequence that contains the minimal promoter for the
ranscription of the subgenomic RNA (nt 7579–7603) (Le-
is et al., 1990). We identified four mutations in the 5262-
999 sequence that are predicted to result in amino acid
hanges. Using site-directed mutagenesis to introduce
hese changes into SVToto, one at a time or in various
ombinations, we showed that expression of the full
VPZF phenotype requires three of the four mutations
hown in Table 3, namely those at nt 6627, 7543, and
593. Thus the mutation at nt 5750, which changes the
pal codon to a Cys codon, is not required. The most
ritical change is that at nt 7593; nevertheless, this mu-
ation alone is not sufficient to produce resistance to PZF.
hen combined with either the mutation at nt 6627 or
hat at 7543, partial resistance resulted. When both of
hese mutations were combined with that at nt 7593, the
ull SVPZF phenotype was observed.
The mutation at nt 7593 has two effects: it not only
changes the Pro at position 609 to Thr but also changes
the 25 position of the promoter for the synthesis of the
subgenomic RNA. It is noteworthy that the C at this
position is invariant among the alphaviruses (Strauss
and Strauss, 1994). However, because it is difficult to
understand how a change in the promoter could lead to
PZF resistance, we favor the idea that the nt 7593 muta-
tion contributes to PZF resistance because of the result-
ing amino acid change in nsP4.
Structures have now been described for all classes of
nucleic acid polymerases, DNA-dependent DNA and
RNA polymerases (Doublie et al., 1998; Sousa et al.,
1993), and RNA-dependent DNA and RNA polymerases
(Huang et al., 1998; Hansen et al., 1997; Lesburg et al.,
999). It is clear from this body of work that all of these
olymerases share common structural features (struc-
ures of polymerases are generally represented as a
lightly flexed right hand, with fingers, thumb, and palm
ubdomains; the palm domain contains the catalytic site)
nd have a common catalytic mechanism (Steitz, 1998).
ecause no structure has been described for the alpha-
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68 LIN ET AL.virus nsP4, we generated a molecular model of nsP4,
using as reference molecules the poliovirus RDRP (Han-
sen et al., 1997) and the HIV reverse transcriptase
(Huang et al., 1998), an RNA-dependent DNA polymer-
ase. Making use of this model, we located the three
positions on nsP4 at which the amino acid changes
required for full PZF resistance occurred. In our model,
residue 287 is positioned in a loop at the tip of the fingers
domain, and residues 592 and 609 are positioned at the
base of the thumb domain.
Given that SVPZF, in contrast to SVSTD, can replicate in
cells with decreased levels of UTP and CTP, we suggest
that the amino acid changes in SVPZF nsP4 alter the
inding properties of the SV PZF RDRP for its rNTP sub-
strates. Furthermore, because all DNA and RNA poly-
merases appear to share a common structure and cat-
alytic mechanism, we anticipate that we will be able to
apply what has been learned about other polymerases
(e.g., the HIV RT, Huang et al., 1998; the T7 DNA poly-
merase, Doublie et al., 1998; and the bacteriophage
RB69, a close relative of T4 phage, gp43 protein, a DNA
polymerase, Brautigam and Steitz, 1998) to our molecular
model of the SV RDRP.
When a DNA or an RNA polymerase extends a primer
strand, it must choose at each step from a pool of four
different substrate molecules, dNTPs or rNTPs, respec-
tively; clearly, the choice as to the correct NTP is deter-
mined not only by the amino acid residues surrounding
the rNTP binding pocket of the enzyme but also by the
positioning of the template-primer that is bound to the
polymerase. When the correct NTP is positioned in the
binding site and a proper Watson-Crick base-pair is
formed, the polymerase undergoes a conformational
change to a “closed” form such that the fingers domain is
flexed inward toward the palm domain where the cata-
lytic site is located, trapping the template strand and the
NTP substrate (Brautigam and Steitz, 1998; Steitz, 1998;
Huang et al., 1998). Crystal structures of polymerases to
which are bound a template-primer and an incoming
NTP molecule clearly show multiple interactions be-
tween the NTP and amino acids in the fingers domain.
Furthermore, as has been shown with the HIV-RT, an
amino acid change in the fingers domain can alter the
specificity of the enzyme with respect to the binding of
nucleoside analog inhibitors, thereby making the NTP
binding pocket more specific for the natural substrate
(Boyer et al., 1994). Thus an amino acid change in the
fingers domain of the SVPZF RDRP might reasonably be
xpected to alter the geometry of the active site of the
DRP, and as a result its binding properties for its rNTP
ubstrate. Less clear is how the amino acid changes at
he base of the thumb domain might alter the properties
f the RDRP. The thumb domain is known to be important
n gripping the template-primer (Jacobo-Molina et al.,
993), and it has been implicated in the processivity of
he enzyme. The structure of nevirapine-bound HIV-RT, in ehich this non-nucleoside RT inhibitor is bound to the
ase of the thumb domain, suggests that a disturbance
f the thumb domain can indirectly influence the confor-
ation of the catalytic site (Kohlstaedt et al., 1992). More
pecifically, it has been demonstrated that an amino acid
hange in the thumb domain of the HIV-RT can alter the
onformation of the primer grip and affect the precise
osition of the primer strand in relation to the carboxylate
riad (Das et al., 1996). Thus the amino acid changes we
ave found in the thumb domain of SVPZF nsP4 might well
influence, if only indirectly, the geometry of the rNTP-
binding pocket.
Because the structure shown in Fig. 5 was obtained by
molecular modeling, conclusions concerning the loca-
tion of the residues that are changed in the SVPZF nsP4
an only be regarded as tentative and must await the
rystallization of the protein and the formal determination
f its three-dimensional structure. Nevertheless, the mo-
ecular model may be useful in providing a preliminary or
orking model of the Sindbis virus RDRP.
MATERIALS AND METHODS
ells and viruses
Primary cultures of chicken embryo fibroblasts (CEF),
repared as described previously (Stollar et al., 1976),
ere grown in Eagle’s MEM supplemented with non-
ssential amino acids, glutamine, 5% tryptose phos-
hate, and 5% bovine serum. Ae. albopictus mosquito
ells (C7-10) have also been described previously
Durbin and Stollar, 1984); they were grown in Eagle’s
EM supplemented with nonessential amino acids, glu-
amine, and 5% fetal bovine serum.
Our standard Sindbis virus has been described else-
here (Shenk and Stollar, 1973). Mosquito cell cultures
ere infected at an m.o.i. of 5 PFU/cell (using the titers
s determined on CEF) and maintained after infection,
nless otherwise indicated, at 34.5°C in medium con-
aining 0.2% BSA in place of serum. Media from infected
ultures were harvested 20–24 h after infection, and
irus yields were measured by plaque formation on pri-
ary cultures of CEF. Samples to be titrated were diluted
n 10-fold steps in PBS containing 0.1% BSA, and 0.5 ml of
ppropriately diluted samples was adsorbed to the cell
onolayers in 60-mm plates for 60 min at 34.5°C. The
irus was then removed, and the monolayers were over-
aid with 2.5 ml of medium containing 0.9% Noble agar.
fter 24 h at 34.5°C, 2.0 ml of 0.01% neutral red in PBS
as added to the plates, which were then kept for an
dditional 2–3 h at 34.5°C. After removing the remaining
eutral red, the plaques were counted.
lasmids and bacteriapToto1101 (13638 bp) contains a cDNA copy of the
ntire SV genome immediately downstream of an SP6
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69SINDBIS VIRUS MUTANT ENCODES ALTERED RNA POLYMERASEpromoter (Rice et al., 1987). Infectious RNA transcripts
generated from pToto, as described previously, were
used to transfect primary cultures of CEF (Mi et al., 1989).
Recombinant DNA techniques and site-directed
mutagenesis
DNA manipulations were performed by standard pro-
cedures (Sambrook et al., 1989). Site-directed mutagen-
esis was carried out using the QuikChange kit pur-
chased from Stratagene (La Jolla, CA). SVPZF cDNA was
prepared as follows: CEF were first infected with SVPZF at
n m.o.i. of 0.01 PFU/ml. After 24 h at 37°C, virus was
arvested and the viral RNA was prepared as previously
escribed (Durbin and Stollar, 1986). After clarification of
he medium, first at 500 g for 10 min. and then at 15,000
for 10 min, each 30 ml of clarified medium was pelleted
hrough 6.5 ml of 15% (w/w) sucrose in TNE (0.05 M Tris,
H 8.0, 0.1 M NaCl, 0.001 M EDTA) by centrifugation at
6,000 rpm at 4°C in a Beckman SW27 rotor. The pel-
eted virus was suspended in TNE containing 0.5% SDS
nd 250 mg proteinase K/ml. After incubation at 37°C for
30 min, the RNA was deproteinized by phenol extraction
and then precipitated with ethanol. First-strand cDNA
was made by incubating the viral RNA with SuperScript
II RT (BRL), and second strand was made using Esche-
richia coli DNA polymerase in the presence of E. coli
DNA ligase and RNase H. The construction of the re-
combinant pToto plasmids containing cDNA sequences
derived from SVPZF is described below.
Toto:SVPZF:5262-7999
A deleted form of pToto, pDToto11439 (Fig. 6), was
ade by deleting the sequence between the two StuI
ites at nt 8571 and 10770 (the nucleotide numbering for
Toto begins with the SV genome RNA, which is then
FIG. 6. pDToto11439, a deleted form of pToto, was made by deleting
he sequence between the two StuI sites at nt 8571 and 10770. The
nucleotide numbering for pToto begins with the first base of the SV
RNA, followed by the vector sequence.ollowed by the vector sequence). SVPZF cDNA and
DToto11439 were digested with SpeI (nt 5262) and AatIInt 7999). The 2737-bp fragment from the SVPZF cDNA
igestion was then ligated to the 8702-bp piece from the
DToto11439 digestion to give pDToto:SVPZF:5262-7999.
he AatII–SacI fragment (nt 7999–13552) from pToto 1101
as then substituted for the corresponding fragment in
DTotoSVPZF:5262-7999 to give a complete infectious
clone.
pToto:SVPZF:41-2784
The cloning strategy for pToto:SVPZF:41-2784 was sim-
lar to that used to make pToto:SVPZF:5262-7999 except
that the SVPZF cDNA and pDToto11439 were digested with
feI (restriction sites at nucleotides 41 and 2784, see Fig
) instead of with SpeI and AatII. The orientation of the
VPZF cDNA insert was checked by digestion with EcoRV
restriction sites at nt 2750 and 6878).
Toto:SVPZF:2784-7999
pDToto11439 and SVPZF cDNA were digested with MfeI
nt 41 and 2784) and AatII (nt 7999). The nt 7999-41
ragment from the former was ligated to the nt 2784-7999
ragment from the latter, giving the intermediate plasmid
DD Toto:SVPZF:2784-7999. The deleted sequence be-
ween the StuI sites (nt 8571–10774) was replaced as
escribed above, and the deletion between the MfeI
ites (nt 41–2784) was filled by inserting the correspond-
ng sequence from pDToto11439.
Toto:SVPZF:41-7999
This plasmid was assembled by digesting pDToto:
VPZF:2784-7999 and pToto:SVPZF:41-2784 with MfeI and
combining the appropriate fragments.
pToto:SVPZF:5262-7334 and pToto:SVPZF:7334-7999
Both pToto1101 and pDToto:SVPZF:5262-7999 (see
above) were digested with BamHI (restriction sites at nt
4633 and 7334). The 2701-bp fragment from the latter
was then ligated to the 10937-bp fragment from the
former to give pToto:SVPZF:5262-7334. To construct pToto:
VPZF:7334-7999, the BamHI fragment from pDToto11439
was ligated to the 10937-bp sequence that was produced
by BamHI digestion of pToto:SVPZF:5262-7999.
Molecular modeling of SV nsP4
The amino acid sequence of Sindbis virus nsP4 was
translated from the nucleotide sequence (gb_vi:sincg).
Amino acid sequences for poliovirus and HIV-1 were
taken from accession numbers p03301 and p03366, re-
spectively. Conserved motifs from the three sequences
were aligned according to Poch et al. (1989). The molec-
ular model of SV nsP4 was generated with Look 3.0
(Molecular Application Group) either using Polio3D (PDB:
1RDR) or HIV-RT (PDB:1RTD) as template. The resulting
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70 LIN ET AL.structures were then energy refined and displayed with
Ribbons.
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